AzTrials
AzTrials

Nociceptive PainNCT06696781

NOL Index in Response to Pacemaker Stimulation

An observational study of Nociceptive Pain, run by Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu at 1 site in Romania.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Nociception Level Index (NOL Index) utilizes various signals to assess the balance of nociception and antinociception during anesthesia. Its correlation with nociceptive stimuli and opioids is known, but its response to isolated heart rate changes remains uncertain. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Nociceptive Pain
What is being tested?
Pacemaker stimulation
Type of treatment
Surgery or procedure
How many people
20 participants
Where
1 siteRomania
Study dates
18 Nov 2024to 1 Jul 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Mechanically ventilated postoperative adult patients, admitted to the ICU within 6 hours after elective cardiac surgery.

Who may be able to join

  • Informed consent
  • Preoperative and postoperative sinus rhythm (50-90 bpm)
  • Norepinephrine support < 100 ng/kg/min

Who cannot join

  • Redo or emergent surgery
  • History of any cardiac arrhythmia
  • Any cardiocirculatory support other than norepinephrine
  • Perioperative treatment with beta-blockers, calcium-channel blockers or ivabradine

Trial locations and contacts

1 site in 1 country.

Romania1 site
  • "Prof CC Iliescu" Emergency Institue for Cardiovascular Diseases

    Bucharest, 022328

Other trials in Romania

About this study

Official title: NOL Index in Response to Pacemaker Stimulation in Open-heart Surgery

The Nociception Level Index (NOL Index) utilizes various signals to assess the balance of nociception and antinociception during anesthesia. Its correlation with nociceptive stimuli and opioids is known, but its response to isolated heart rate changes remains uncertain. The aim is to investigate how cardiac pacing affects the NOL Index.

Read the detailed description

The Nociception Level Index (NOL Index) represents an innovative approach to monitoring nociception during general anesthesia, utilizing a combination of signals from photoplethysmography, accelerometry, thermometry, and skin conductance to assess the balance between nociceptive and antinociceptive states. Research has already established how the NOL Index correlates with both nociceptive stimuli and opioid levels, providing valuable insights into patient responses. However, the impact of changes in heart rate, specifically through isolated cardiac pacing, on the NOL Index is not yet clear. The primary goal of this study is to explore and understand how cardiac pacing might influence the readings of the NOL Index, potentially offering a new dimension to managing anesthesia effectively.

Being tested
Pacemaker stimulation
Keywords
cardiac surgery, nociception, NOL index, pacemaker
Medical subject headings
Nociceptive Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pacemaker stimulationProcedure or surgery

    We deactivate the pacemaker to establish baseline measurements of NOL, bispectral index (BIS), mean arterial pressure (MAP), and heart rate (HR), recorded every minute for 5 minutes. We then adjust the pacemaker to 90 bpm and 110 bpm in subsequent 5-minute phases to assess the physiological responses. After deactivating the pacemaker to analyze washout effects, we reactivate it at 110 bpm to observe any changes. A temporary disconnection of the NOL monitor for 1 minute tests system reliability, followed by continued monitoring at the same rate for an additional 5 minutes. Each measurement phase averages data from the last 10 seconds each minute to ensure accuracy and reduce artifacts.

Study groups in NCT06696781
Study groupRoleWhat they receive
PacemakerMechanically ventilated postoperative adult patients, admitted to the intensive care unit (ICU) within 6 hours after elective cardiac surgery, undergo pacemaker stimulation at various rates to observe how this influences the NOL Index.
Receives: Procedure: Pacemaker stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. NOL index

    The Nociception Level Index (NOL Index) quantitatively evaluates the balance between nociception and antinociception in mechanically ventilated postoperative adult patients after elective cardiac surgery, utilizing a multiparametric approach that includes photoplethysmography, accelerometry, thermometry, and skin conductance.

    Measured: Every minute during seven 5-minute intervals under various pacemaker settings, totaling 35 minutes of monitoring.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2024
  2. Study start18 Nov 2024
  3. Primary completion1 Jun 2025
  4. Study completion1 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06696781
Sponsor's protocol ID
33964
Status last verified
Aug 2025
First submitted
17 Nov 2024
Last updated
11 Aug 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Balan C, Barbulescu RT, Dumitrache A, Fodoroiu A, Morosanu B, Nica A, Stanculea I, Stoian I, Valeanu L, Wong A, Bubenek-Turconi SI. Nociception level index response to pacemaker stimulation. J Clin Monit Comput. 2025 Dec;39(6):1309-1316. doi: 10.1007/s10877-025-01377-w. Epub 2025 Nov 3.

    PubMed 41182599

Questions about this trial

What is this clinical trial studying?

An observational study of Nociceptive Pain, run by Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu at 1 site in Romania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Romania. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

NOL index (time frame: Every minute during seven 5-minute intervals under various pacemaker settings, totaling 35 minutes of monitoring.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06696781, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in